Top three Cancer treatment centers in the U.S.
Written by Angie Mansfield
Cancer Meeting Its Match at These Facilities
Cancer has long been one of the most feared diagnoses in modern medicine.
Claiming new victims every day, this disease can strike anyone, and its treatment can have a devastating effect on the patient's body.
But hospitals and researchers are fighting back. Here are just a few of the facilities striking a major blow against all kinds of cancer:
University of Texas MD Anderson Cancer Center
For 10 of the past 12 years, MD Anderson was ranked #1 in cancer care in the U.S. News & World Report's Best Hospitals survey, and is regarded by many to be the best cancer hospital in the United States.
In 2012, the center treated more than 115,000 patients. It also invested more than $647 million in cancer research, making it a leader in the fight against this deadly disease.
Memorial Sloan-Kettering Cancer Center
The world's oldest dedicated cancer hospital, Sloan-Kettering was also the first to develop services to address the psychiatric effects of cancer, relief of cancer pain, and genetic counseling.
A long-time leader in cancer surgery and treatment, this hospital earned its #2 ranking in the U.S. News & World Report survey.
Also leading other hospitals in research, Sloan-Kettering is working on using the body's immune system to fight cancer and bringing laboratory discoveries to real-world patients.
One of the first cancer centers to receive a designation from the National Cancer Institute, the Mayo Clinic has 450 doctors and scientists collaborating to reduce cancer's effect on patients and their families.
Mayo believes that treatment should be a collaborative affair between clinicians, specialists, and researchers. Working as a team, these professionals can more effectively fight the disease and help patients cope.
With 11 major cancer research programs currently active, and 20,000 new patients treated every year, Mayo is another facility on the leading edge of the fight against cancer.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Sidney Kimmel cancer center was founded in 1973 and got its National Cancer Institute designation the same year.
Dedicated to staying on the cutting edge of the most advanced research and delivering the very best treatments to patients, Sidney Kimmel earns its spot among the top cancer centers in the world.
Drawing its faculty from Johns Hopkins University, Sidney Kimmel uses medicine, science, engineering, physics, and other disciplines to stay ahead of the curve. It runs laboratory research on cancer biology, immunology, chemical treatments, and more; along with organ-specific cancer research.
These scientists then bring the very latest in treatment options to Johns Hopkins patients. The Sidney Kimmel center also provides genetic testing for those who have a high risk of various types of cancer.
Thanks to these institutions and many more, new treatments for cancer are being developed all the time.
These centers are helping to provide early detection, the latest in cutting-edge medicine and research, and new ways to help patients cope with the physical and emotional toll of cancer.
About the Author
Freelance blogger Angie Mansfield covers a variety of subjects for small business owners. From business growth to marketing to content writing, her work will give you tips to keep your business running smoothly.
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.